Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Comparing Safety Profiles and Health Care Costs
Panelists discuss how optimizing safety and cost-efficiency are central to improving adherence and overall health care value.
EP: 1.Clinical and Economic Burden of Schizophrenia
EP: 2.Symptoms Associated with Schizophrenia
EP: 3.Risk Factors for Schizophrenia
EP: 4.Challenges of Early and Accurate Diagnosis in Schizophrenia
EP: 5.Exploring Schizophrenia Progression and Its Impact on Quality of Life
EP: 6.Consequences of Relapse in Schizophrenia Care
EP: 7.Addressing Social Determinants of Health and Unmet Needs in Schizophrenia
EP: 8.Current Treatment Guidelines for Schizophrenia
EP: 9.First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing
EP: 10.Switching Therapies, Managing Adverse Effects, and Adherence Challenges
EP: 11.Xanomeline/Trospium Mechanism of Action, Efficacy, and Safety
EP: 12.Use of Xanomeline/Trospium in Clinical Practice
Now Viewing
EP: 13.Comparing Safety Profiles and Health Care Costs
EP: 14.Emerging Therapies in Schizophrenia
Panelists discuss how safety profiles significantly impact both clinical outcomes and economic sustainability in schizophrenia management. Drugs with fewer adverse effects tend to improve adherence and lower hospital readmissions.
Panelists discuss how second-generation and novel agents generally offer better metabolic and neurologic safety, which can translate into reduced long-term health care spending.
Panelists discuss how evaluating total cost of care rather than upfront medication cost ensures more rational treatment decisions and sustainable systemwide outcomes.
Related Videos
